ClinicalTrials.Veeva

Menu

KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

O

Ochsner Health System

Status

Completed

Conditions

Strabismus
Emergence Delirium

Treatments

Drug: Dexmedetomidine

Study type

Observational

Funder types

Other

Identifiers

NCT03779282
Pro00014439

Details and patient eligibility

About

Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we study its application in strabismus surgery.

Enrollment

90 patients

Sex

All

Ages

Under 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ASA I/II children undergoing outpatient strabismus surgery

Exclusion criteria

  • anything not meeting the above

Trial design

90 participants in 2 patient groups

control
Description:
pediatric patients undergoing outpatient strabismus surgery, and not receiving ketodex
study
Description:
pediatric patients undergoing outpatient strabismus surgery, and receiving ketodex
Treatment:
Drug: Dexmedetomidine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems